Zobrazeno 1 - 10
of 361
pro vyhledávání: '"Philip Poortmans"'
Autor:
Emma J Harris, Mukesh Mukesh, Rajesh Jena, Angela Baker, Harry Bartelink, Corrinne Brooks, June Dean, Ellen M Donovan, Sandra Collette, Sally Eagle, John D Fenwick, Peter H Graham, Jo S Haviland, Anna M Kirby, Helen Mayles, Robert A Mitchell, Rosalind Perry, Philip Poortmans, Andrew Poynter, Glyn Shentall, Jenny Titley, Alistair Thompson, John R Yarnold, Charlotte E Coles, Philip M Evans, on behalf of the IMPORT Trials Management Group
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 1, Iss 3 (2014)
Background: Whole-breast radiotherapy (WBRT) is the standard treatment for breast cancer following breast-conserving surgery. Evidence shows that tumour recurrences occur near the original cancer: the tumour bed. New treatment developments include in
Externí odkaz:
https://doaj.org/article/1dda8bc383744990b5ba37123bbe3057
Autor:
H.J. Burstein, G. Curigliano, B. Thürlimann, W.P. Weber, P. Poortmans, M.M. Regan, H.J. Senn, E.P. Winer, M. Gnant, Stephan Aebi, Fabrice André, Carlos Barrios, Jonas Bergh, Herve Bonnefoi, Denisse Bretel Morales, Sara Brucker, Harold Burstein, David Cameron, Fatima Cardoso, Lisa Carey, Boon Chua, Eva Ciruelos, Marco Colleoni, Giuseppe Curigliano, Suzette Delaloge, Carsten Denkert, Peter Dubsky, Bent Ejlertsen, Florian Fitzal, Prudence Francis, Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy Garber, Michael Gnant, William Gradishar, Bahadir Gulluoglu, Nadia Harbeck, Chiun-Sheng Huang, Jens Huober, Andre Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith Regan, Isabella Rubio, Hope Rugo, Emiel Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Spanic, Petra Tesarova, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, Walter P. Weber, Eric P. Winer, Binghe Xu
Publikováno v:
Annals of oncology
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the
Autor:
Walter Paul Weber, Jane Shaw, Andrea Pusic, Lynda Wyld, Monica Morrow, Tari King, Zoltán Mátrai, Jörg Heil, Florian Fitzal, Shelley Potter, Isabel T. Rubio, Maria-Joao Cardoso, Oreste Davide Gentilini, Viviana Galimberti, Virgilio Sacchini, Emiel J.T. Rutgers, John Benson, Tanir M. Allweis, Martin Haug, Regis R. Paulinelli, Tibor Kovacs, Yves Harder, Bahadir M. Gulluoglu, Eduardo Gonzalez, Andree Faridi, Elisabeth Elder, Peter Dubsky, Jens-Uwe Blohmer, Vesna Bjelic-Radisic, Mitchel Barry, Susanne Dieroff Hay, Kimberly Bowles, James French, Roland Reitsamer, Rupert Koller, Peter Schrenk, Daniela Kauer-Dorner, Jorge Biazus, Fabricio Brenelli, Jaime Letzkus, Ramon Saccilotto, Sarianna Joukainen, Susanna Kauhanen, Ulla Karhunen-Enckell, Juergen Hoffmann, Ulrich Kneser, Thorsten Kühn, Michalis Kontos, Ekaterini Christina Tampaki, Moshe Carmon, Tal Hadar, Giuseppe Catanuto, Carlos A. Garcia-Etienne, Linetta Koppert, Pedro F. Gouveia, Jakob Lagergren, Tor Svensjö, Nadia Maggi, Elisabeth A. Kappos, Fabienne D. Schwab, Liliana Castrezana, Daniel Steffens, Janna Krol, Christoph Tausch, Andreas Günthert, Michael Knauer, Maria C. Katapodi, Susanne Bucher, Nik Hauser, Christian Kurzeder, Rosine Mucklow, Pelagia G. Tsoutsou, Atakan Sezer, Güldeniz Karadeniz Çakmak, Hasan Karanlik, Patricia Fairbrother, Laszlo Romics, Giacomo Montagna, Cicero Urban, Melanie Walker, Silvia C. Formenti, Guenther Gruber, Frank Zimmermann, Daniel Rudolf Zwahlen, Sherko Kuemmel, Mahmoud El-Tamer, Marie Jeanne Vrancken Peeters, Orit Kaidar-Person, Michael Gnant, Philip Poortmans, Jana de Boniface
Publikováno v:
Weber, W, Shaw, J, Pusic, A, Wyld, L, Morrow, M, King, T, Matrai, Z, Potter, S & et al. 2022, ' Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy ', Breast, vol. 63, pp. 123-139 . https://doi.org/10.1016/j.breast.2022.03.008
The Breast
Breast, 63, 123-139. Churchill Livingstone
The Breast
Breast, 63, 123-139. Churchill Livingstone
Funder: Amgen
Funder: Roche
Funder: Universitätsspital Basel
Funder: Merck
Funder: AstraZeneca
Funder: Pfizer
AIM: Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has
Funder: Roche
Funder: Universitätsspital Basel
Funder: Merck
Funder: AstraZeneca
Funder: Pfizer
AIM: Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d4369e1b7354dcd622b3df43fe8ae2d
https://eprints.whiterose.ac.uk/185701/1/1-s2.0-S0960977622000583-main.pdf
https://eprints.whiterose.ac.uk/185701/1/1-s2.0-S0960977622000583-main.pdf
Autor:
Dirk De Ruysscher, Tine Engberg Damsgaard, Philip Poortmans, Naama Hermann, Oreste Gentilini, Birgitte Vrou Offersen, Wies Maarse, Trine Tramm, Zoltan Matrai, Miri Sklair-Levi, Thorsten Kühn, Orit Kaidar-Person, Liesbeth J. Boersma
Publikováno v:
Radiotherapy and oncology
Kaidar-Person, O, Hermann, N, Poortmans, P, Offersen, B V, Boersma, L J, de Ruysscher, D, Tramm, T, Kühn, T, Engberg Damsgaard, T, Gentilini, O, Maarse, W, Sklair-Levi, M & Mátrai, Z 2021, ' A multidisciplinary approach for autologous breast reconstruction : A narrative (re)view for better management ', Radiotherapy and Oncology, vol. 157, pp. 263-271 . https://doi.org/10.1016/j.radonc.2021.01.036
Kaidar-Person, O, Hermann, N, Poortmans, P, Offersen, B V, Boersma, L J, de Ruysscher, D, Tramm, T, Kühn, T, Engberg Damsgaard, T, Gentilini, O, Maarse, W, Sklair-Levi, M & Mátrai, Z 2021, ' A multidisciplinary approach for autologous breast reconstruction : A narrative (re)view for better management ', Radiotherapy and Oncology, vol. 157, pp. 263-271 . https://doi.org/10.1016/j.radonc.2021.01.036
Breast reconstruction and oncoplastic surgery have become an important part of breast cancer care. The use of autologous breast reconstruction (ABR) has evolved significantly with advances in microsurgery, aiming to reduce donor site complications an
Publikováno v:
Journal of Medical and Radiation Oncology. 1:83-98
"More than 10 years ago, two pivotal trials, the Ontario Clinical Oncology Group trial and START B trial, firmly established that hypofractionated radiation therapy (RT) of 40–42.5 Gy in 15–16 fractions over 3 weeks after breast conserving surger
Autor:
Paula H.M. Elkhuizen, Erik van Werkhoven, Alain Fourquet, Femke van der Leij, Sophie C.J. Bosma, Marc J. van de Vijver, Marlous Hoogstraat, Liesbeth J. Boersma, Harry Bartelink, Philip Poortmans, Michiel de Maaker
Publikováno v:
Radiotherapy and oncology
Radiotherapy and oncology, 156, 127-135. Elsevier Ireland Ltd
Radiotherapy and Oncology, 156, 127-135. Elsevier Ireland Ltd
Radiotherapy and oncology, 156, 127-135. Elsevier Ireland Ltd
Radiotherapy and Oncology, 156, 127-135. Elsevier Ireland Ltd
Purpose: To investigate risk factors for local recurrence (LR) after breast conserving therapy in young breast cancer patients randomized in the "Young Boost Trial". Material & methods: In the "Young Boost Trial" 2421 patients
Autor:
Mateja Steinacher, Pierfrancesco Franco, Ivica Ratosa, Monica Emilia Chirilă, Philip Poortmans, Elvisa Kozma, Radovan Vojtíšek
Publikováno v:
Radiotherapy and oncology
Background and purpose: We aimed to assess the prescription preference about hypofractionated radiation therapy (HFRT) for breast cancer (BC) patients amongst radiation oncologists (ROs) practicing in Europe and to identify restraints on HFRT utilisa
Autor:
Philip Poortmans, Nicolaus Andratschke, Coen W. Hurkmans, Angelo Fillipo Monti, Nick Reynaert, Enrico Clementel, Coreen Corning, Jonas Willmann, Warren Grant
Publikováno v:
Radiotherapy and oncology
Purpose: The EORTC Radiation Oncology Group uses a Facility Questionnaire (FQ) to collect information from its member radiation oncology departments. We analysed the FQ database for patient-related workload, staffing levels and infrastructure to dete
Autor:
Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert Hills, Zulian Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, Stewart Anderson, Richard Gelber, Luca Gianni, William Jacot, Heikki Joensuu, Alvaro Moreno-Aspitia, Martine Piccart, Michael Press, Edward Romond, Dennis Slamon, Vera Suman, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Fran Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles Geyer, Marc Spielmann, Pinuccia Valagussa, Kathy Albain, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith Regan, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I Pritchard, Sandra M Swain
Publikováno v:
The Lancet. Oncology
The lancet oncology
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) 2021, ' Trastuzumab for early-stage, HER2-positive breast cancer : a meta-analysis of 13 864 women in seven randomised trials ', The Lancet Oncology, vol. 22, no. 8, pp. 1139-1150 . https://doi.org/10.1016/S1470-2045(21)00288-6
The lancet oncology
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) 2021, ' Trastuzumab for early-stage, HER2-positive breast cancer : a meta-analysis of 13 864 women in seven randomised trials ', The Lancet Oncology, vol. 22, no. 8, pp. 1139-1150 . https://doi.org/10.1016/S1470-2045(21)00288-6
Background: Trastuzumab targets the extracellular domain of the HER2 protein. Adding trastuzumab to chemotherapy for patients with early-stage, HER2-positive breast cancer reduces the risk of recurrence and death, but is associated with cardiac toxic
Autor:
W. Vingerhoed, Charlotte Billiet, Dirk Verellen, R. Weytjens, M. Machiels, W. Bauwens, Philip Poortmans, Piet Dirix, Paul Meijnders, P. Huget, Orit Kaidar-Person
Publikováno v:
Clinical Oncology (Royal College of Radiologists (Great Britain)
Clinical oncology, 33(3), E166-E171. Elsevier Science
Clinical Oncology
Clinical oncology
Clinical oncology, 33(3), E166-E171. Elsevier Science
Clinical Oncology
Clinical oncology